oo22-202X/ 78/ 7101-0056$02.oo/ 0 THE Jo fiNA L O F INVESTIGATIVE DERMATOLOGY, 71:56-58,1978 Vol. 71, NO.1 Copyright © 1978 by The Williams & Wilkins Co. Printed in U.S.A. I

Monocytes, , and Their Diseases in Man

MARTiN J. CLINE, M.D. Division of Hematology-Oncology, Department of Medicine, University of California School of Medicine, Los Angeles, California, U.S.A.

Mononuclear are a widely distributed sys­ pool in a ratio of 1:3, (iii) leave the exponen­ tem of cells involved in host defense functions, immu­ tially with a half life of 8.4 hr, (iv), the half life may be prolonged nologic reactions, disposal of unwanted organic and in­ in patients with monocytosis and shortened in patients with \ organic materials, and synthesis of biologically active acute infection or splenomegaly, and (v) the normal compounds such as complement components and pros­ turnover rate averages 7 X lOG cells pel' hour pel' kilogram of taglandins. The system includes early precursor cells in body weight. the , blood monocytes, alveolar and peri­ Available data suggest that there is no significant reentry of toneal macrophages, sinusoidal lining cells in the spleen, monocytes into the bloodstream once they have left the circu­ and Kupffer cells in the liver. We have recently come to lation. They enter the tissues and mature to macrophages. The understand the biology of these interesting cells and the major source of mononuclear phagocytes accumulating at in­ diseases they produce. flammatory foci is the monocyte precursors of the bone marrow [6]. Under noninflammatory conditions tissue macrophages may also arise from endogenous replicating cell populations, as Mononuclear phagocytes constitute a cell line that includes well as from man-ow precursors [7]. and in the bone marrow, the mono­ cyte as a cell of intermediate differentiation in the blood, and METABOLISM OF MONONUCLEAR PHAGOCYTES mature macrophages in the tissues. Tissue macrophages are The metabolism and enzymatic activities of mononuclear \ heterogeneous and include free alveolar and peritoneal macro­ phagocytes change profoundly with cell maturation and with phages, Kupffer cells, and the macrophages of the splenic changes in cellular environment [2,8]. The principal energy sinusoids. The concept of a continuum of cells from bone source for human monocytes and for most tissue macrophages marrow precursors to the mature tissue macro phages is impor­ is glycolysis, even under aerobic conditions. In contrast, the tant to an understanding of the function and metabolism of metabolism of the nonphagocytic human alveolar these cells. appears to be primaril'y aerobic [2,9]. MATURATION OF MONONUCLEAR PHAGOCYTES Macrophages have an active lipid metabolism, and phospho­ lipid synthesis is increased during . The more Mononuclear phagocytes share a common progenitor cell mature cells of the series have abundant rough endoplasmic with the granulocytic series. The earliest cells of these series reticulum and a high rate of protein synthesis. Much of this are undifferentiated lymphocyte-like cells [1]. When undiffer­ synthetic activity is directed toward the production oflysosomal entiated monoblasts mature and form a complex Golgi appa­ enzymes, but other biologically active compounds, such as ratus and a definite granule population, they are identifiable complement components, are also made in these cells. and are designated promonocytes. The has a high The many hydrolytic enzymes localized within the lysosomal I nucleus-to-cytoplasm ratio, basophilic cytoplasm, and some cell fraction [2] probably have a major role in the digestion of peroxidase activity. The cell generally shows little phagocytic phagocytized organic materials, including erythrocytes and mi- \ activity. With maturation to the monocyte level, the activity of croorganisms. Some lysosomal enzymes may also be secreted certain acid hydrolases and the phagocytic ability increase by macro phages [10]. [2,3]. The transformation from to mature macrophage Tissue macrophages (synonym: ) are later stages is associated with changes in cellular composition and m e­ of maturation of monocytes. They are large cells 20 to 80 !Lm in tabolism. With maturation, the number of cytoplasmic lyso­ diameter, with one or more large vesicular nuclei and abundant somes and mitochondria increases, and the activity levels of cytoplasmic lysosomes, numerous mitochondria, and other in­ associated lysosomal and mitochondrial enzymes change Cor- \ clusions. The cells move slowly, and the movement appears to respondingly. Differentiation to mature macrophages and the depend on the complex of microfllaments. Immature macro­ accompanying increase in specific activity of certain lysosomal phages are capable of DNA synthesis and cell division, but enzymes are dependent on intact protein synthesis. When mac­ ultimately immature cells give rise to mature nondividing mac­ rophages are cultivated in vitro under circumstances in which rophages. These macrophages may form multinucleate giant pinocytic activity is reduced, the many secondary lysosome cells, probably by the process of cell fusion. These giant cells, gradually disappear from the cytoplasm. Such influence of \ seen in chronic granulomatous reactions, are rich in lysosomes environmental factors on the cellular level oflysosomal enzymes and hyd.rolytic enzymes. seen in vitro probably reflects the situation in the intact animal in which the functional status of the macrophages is adaptable. KINETICS OF MONONUCLEAR PHAGOCYTES This phenomenon is most clearly demonstrated in macro phages The studies of Meuret, Bammert, and Hoffmann [4,5] indi­ "activated" by infection with an intracellular parasite, such a cate the following: (i) normally blood monocyte counts oscillate Mycobacterium tuberculosis. These mononuclear with a cycle frequency of 3 to 6 days, (ii) the total blood are larger, spread more readily on a sUlface, and have increased \ monocyte pool comprises a circulating pool and a marginated metabolic and microbicidal activity. Activation is thought to be mediated by products of sensitized lymphoid cells [11]. \ Supported by USPHS Grant CA 15688. Dr. Cline is a recipient of an endowment from the Ambrose and Gladys Bowyer Foundation. FUNCTIONS OF MONONUCLEAR PHAGOCYTES Reprint requests to: Martin J. Cline, M.D., Division of Hematology­ Oncology, Department of Medicine, University of California School of Five major areas of mononuclear phagocyte function have Medicine, Los Angeles, California 90024. been identified: (i) defense against microorganisms, (ii) removal Abbreviation: of dead or damaged cells, cell debris, and inorganic material , \ eSA: colony stimulating activity (iii) cooperative and effector functions in immune responses, \ 56 July 1978 MONOCYTES, MACROPHAGES, AND THEIR DISEASES IN MAN 57

(iv) regulatory interactions in hematopoiesis, and (v) synthesis proliferative response to mitogen and the generation of helper of other biologically active compounds, such as complement T cells requires interaction with macro phages [20]. Macrophage components and prostaglandins. These cells may also play a interactions with T cells are complex and require cells that are role in wound repair and remodeling of embr~'onic tissues. genetically compatible. In summary, it is apparent that lymphoid cells may activate DEFENSE AGAINST MICROORGANISMS macrophages and that macrophages may activate and direct Monocytes and macrophages have an important role in the lymphocytes. defense against a variety of infectious organisms [2,8,12]. They are the principal cells involved in killing intracellulaj' parasites CELL-MEDIATED CYTOTOXICITY AND ANTITUMOR such as Mycobacteria, Listeria, and Toxoplasma [13]. Macro­ IMMUNITY phages participating with immunocompetent cells may also kill virus and virus-infected cells, and have been demonstrated to The role of monocytes and macrophages in the control of produce interferon and to enhance lymphocyte production of neoplasia is of considerable interest but is still uncertain [21]. interferon. It is thought that mononuclear phagocytes may act as effector Mononuclear phagocytes are chemotactically attracted to an cells in various cytotoxic reactions. One form is referred to as infective focus, where they phagocytize the invading organism. antibody-dependent, cell-mediated cytotoxicity (ADCC). This The activated fifth component of complement, as well as factors mechanism depends on the coating of target cells with specific released by mitogen- and antigen-stimulated lymphocytes are antibody and subsequent identification and destruction by ef­ chemotactic for monocytes. fector cells. Mononuclear phagocytes, as well as , Macrophages may accumulate at an infective focus under the can function in ADCC [22]. Macrophage recognition of anti­ influence of another lymphocyte-derived factor, migration-in­ body-coated target cells depends on membrane receptors for hibiting factor. This factor may be the same molecule that the Fc portion of subclasses of IgG antibody. activates macrophages (macrophage-activating factor) and is Monocytes and macrophages also participate in cytotoxic probably one of the inducers of the complex series of metabolic reactions mediated by humoral antibody (cytophilic antibody) changes that result in the "activated" state [14]. that attaches first to the effector cells. This type of antitumor The precise mechanisms by which mononuclear phagocytes cell activity is specific, is mediated by humoral antibody, and is kill ingested microorganisms have not been clearly defined, but effective in initiating macrophage cytotoxicity against neoplas­ they probably involve both oxygen-dependent and -indepen­ tic cells [23]. A third form of macrophage tumoricidal mecha­ dent cell functions [15]. Activated macrophages have been nisms is mediated by a nonimmunoglobulin humoral factor shown to kill some microorganisms more efficiently than non­ derived from immune lymphocytes. This material, referred to activated cells. Monocytes from patients with chronic granu­ as specific macrophage-activating factor, apperu's to act in a lomatous disease (CGD) manifest defective bactericidal and manner similru' to that of cytophilic antibody [23]. fungicidal capacities. Since the defect in CGD is related to Nonspecifically activated macrophages can also kill syngeneic impaired H 20 2 and O2- generation, it is likely that mononuclear tumor cells [24], a phenomenon that has been demonstrated phagocytes share this microbicidal mechanism with granulo­ both in vitro and in vivo. Nonspecific macrophage activation cytes [15]. occurs with intracellular parasitosis, such as Toxoplasma or tuberculosis infection, and in response to certain other biologi­ REMOVAL OF DAMAGED CELLS AND INORGANIC cal materials such as phytohemagglutinin, endotoxin, pyran MATERIALS copolymer, and glucan. Nonspecific activation may be mediated by a vru'iety of lymphocyte products (lymphokines) [14]. Mononuclear phagocytes remove damaged or dying cells. Activated cells ru'e larger, spread more on glass, and have a Macrophages seem able to recognize alterations in the eryth­ greater number of lysosomal particles than unactivated cells. rocyte surface caused by antibody, physical or chemical injUl'Y, Certain of their enzyme activities are decreased; others ru'e or aging. Splenic macrophages remove nuclear remnants and increased. They are better killer cells. precipitated hemoglobin from circulating erythrocytes ("pit­ The mechanisms by which activated macrophages kill tumor ting"). They also ingest immunologically injUl'ed leukocytes cells are not well understood. Killing requires intact energy and . Alveolar macrophages have a special function in production but is independent of DNA, RNA, or protein syn­ clearing particulate material from inspired air [7). thesis. Cytotoxicity does not depend on phagocytosis, but close Macrophages also localize various inorganic materials within cell-to-cell contact is necessru-y. Transfer of lysosomal material tissues. Beryllium, zirconium, and silica cause granulomatous may be important in the killing process [25], and we have tissue reactions, and silica is known to be highly toxic to recently demonstrated that in at least some tumor model sys­ macrophages. tems the killing process is oxygen-independent [26]. COOPERA TIVE FUNCTIONS IN IMMUNE RESPONSES CONTROL OF Mononuclear phagocytes play an important role in both cell­ mediated and humoral immunity [11,16]. They operate both in Monocytes and macrophages may have a regulatory role in the afferent limb of the in antigen processing granulopoiesis related to their elaboration of a humoral factor. and in the efferent limb as effector cells. Monocytes and mac­ The formation of and monocyte colonies in semi­ rophages collect, catabolize, and eliminate certain potentially solid gel cultUl'e is dependent on the presence of stimulating immunogenic materials and retain other immunogenic mole­ substances collectively called colony-stimulating activity (CSA) cules. Mononuclear phagocytes then can selectively present [27]. Although there is considerable biochemical heterogeneity antigen to immunocompetent T and B lymphoid cells [16]. associated with this activity, the best chru'acterized materials Antigen taken up by macrophages is partially degraded in are glycoproteins. In man, the main sources of CSA apperu' to phagolysosomes, but a small fraction may be retained in its be circulating monocytes and tissue macrophages [28,29]. native state for long periods of time [16]. Close contact between Mononuclear phagocytes may thus regulate the production of mononuclear phagocytes and lymphocytes is apparently impor­ granulocytes, as well as their own production. Monocyte CSA tant in the transfer of immunologic information and initiation elaboration can be increased by endotoxin and certain nucleo­ of the immune response [2,17-19]. tides. Macrophages and subclasses of T lymphocytes must interact The role of monocytes and macrophages in the regulation of with certain types of antigen before a maximal B lymphocyte granulopoiesis is still uncertain and will become clearer when response can be expressed. Similarly, optimal T lyml?hocyte the physiological importance of CSA has been better defined. 58 CLINE Vol. 71, No.1

MONONUCLEAR PHAGOCYTE DYSFUNCTION microbicidal activity, and (iii) malignant transformation of SYNDROMES mononuclear phagocytes. Alt hough granulocyte functional disorders have been well REFERENCES described, relatively little is known about functional diseases of 1. Bradley TR, Metcalf D: The growth of mouse bone marrow cells in vitro. Aust J Exp Bioi Med Sci 44:237-299, 1966 monocytes and macrophages. Defects in monocyte chemotaxis 2. Cline MJ: The White Cell. Cambridge, Harvard University Press, are reported in some patients with cancer and in patients and 1975 animals with Chediak-Higashi syndrome. Monocyte accumu­ 3. Nichols BA, Bainton DF: Differentiation of human monocytes in lation in skin windows is impaired by corticosteroids in man. bone marrow and blood. Sequential formation of two granule populations. Lab Invest 29:27-40, 1973 Monocytes from patients with chronic granulomatous disease 4. Meuret G, Bammel't J , Hoffmann G: Kinetics of human monocy­ have defective bactericidal and fungicidal capacities [15]. In the topoiesis. Blood 44:801, 1974 rare genetic deficiency of myeloperoxidase, the monocytes also 5. Meuret G, Batara E, Furste HO: in normal man: have a defective fungicidal capacity, but macrophage killing is Pool size, proliferation activity and DNA synthesis time of pro­ monocytes. Acta Haematol 54:261-270, 1975 normal. 6. Horwitz DA: The development of macrophages from large mono­ Defective monocyte microbicidal function has been demon­ nuclear cells in the blood of patients with inflammatory disease. strated in patients with acute myelomonocytic leukemia, in J Clin Invest 51:760-768, 1972 some patients with lymphoma, and in patients with certain 7. Golde DW: Human pulmonary macl'ophages in disease and neopla­ types of vil'al infections [2]. An acquired defect of human sia, Role of Macrophages in Neoplasia, Wood's Hole Symposium. Edited by M Fink. New York, Academic Press, 1976, pp 171-180 alveolal' function has been delineated in pulmonal'Y alveolal' 8. Territo MC, Cline MJ: Macl'ophages and their disorders in man, proteinosis [30], and recently my colleague, Dr. Territo, has Immunobiology of the Macrophage. Edited by DS Nelson. New demonstrated a defect in monocyte killing activity after bone York, Academic Press, 1976, pp 594-616 marrow transplantation. The common featul'e of all these dis­ 9. Cohen AB, Cline MJ: The human : Isolation, cultivation in vitro, and studies of morphologic and functional orders is an enhanced susceptibility to microbial infection. characteristics. J Clin Invest 50:1390-1398, 1971 10. Werb Z, Gordon S: Elastase secretion by stimulated macrophages. MALIGNANT MONONUCLEAR PHAGOCYTES Characterization and regulation. J Exp Med 142:361-377, 1975 11. Mackaness GB: The monocyte in cellular immunity. Semin Hem­ An understanding of the neoplastic disorders of monocytes atol 7:172-184, 1970 12. Territo MC, Cline MJ: Mononuclear phagocyte proliferation, mat­ and macrophages has been hampered by a cumbersome no­ uration and function. Clin HaematoI4:685-703, 1975 menclature. Nevel'theless, we are beginning to understand these 13. Anderson SE, Remington JS: Effect of normal and activated human diseases in terms of modern cell biology [31]. macrophages on Toxoplasma gondii. J Exp Med 139:1154-1174, Acute monocytic and myelomonocytic leukemia are types of 1974 14. David JR: Macrophage activation by lymphocyte mediators. Fed acute leukemia in which there is a proliferation of hematopoi­ Proc 34:1730-1736, 1975 etic cells with sufficient differentiation to exhibit characteristics 15. Lehrer RI: The fungicidal mechanisms of human monocytes. I. of the mononuclear phagocyte line. Often, a variable admixtUl'e Evidence for myeloperoxidase-linked and myeloperoxidase-in­ of granulocytic elements, probably related to the close associa­ dependent candidacidal mechanisms. J Clin Invest 55:338-436, tion of the stem cells of these cell lines, is present. Acute 1975 16. Unanue ER, Cerottini JC: The function of macrophages in the monocytic leukemia cells exhibit morphological and functional immune response. Semin Hematol 7:225-248, 1970 matUl'ation ranging from blast cells to phagocytic cells with the 17. Greineder DK, Rosenthal AS: The requirement for macrophage­ characteristics of macro phages [2]. They usually contain the lymphocyte interaction in T lymphocyte proliferation induced by nonspecific esterase characteristic of monocytes and macro­ generation of aldehydes on cell membranes. J Immunol 115:932-938, 1975 phages, adhere to glass, may be highly phagocytic, and elabo­ 18. Lipsky PE, Rosenthal AS: Macrophage-lymphocyte interaction: rate substantial quantities of CSA and lysozyme. A chronic Antigen-independent binding of guinea pig lympho­ form of myelomonocytic leukemia is also recognized [32]. cytes by macro phages. J Immunol 115:440-445, 1975 Histiocytic lymphoma has classically been considered as a 19. Cline MJ, Swett VC: The interaction of human monocytes and lymphocytes. J Exp Med 128:1309-1325, 1968 neoplastic proliferation of mononuclear phagocytes. Recent 20. Erb P, Feldmann M: The role of macrophages in the generation of studies, however, suggest that many of the previously described T-helper cells. II. The genetic control of the macrophage T-cell histiocytic lymphomas are in fact large-cell ("immunoblastic") interaction for helper cell induction with soluble antigens. J Exp lymphocytic malignant tumors. Nevertheless, histiocytic lym­ Med 142:460-472, 1975 21. Nelson DS: The Immunobiology of the Macrophage. New York, phomas do occul' where the proliferating cells appear to be of Academic Press, 1976, pp 1-663 the monocyte-macrophage line. 22. Holm G, Hammarstrom S: Haemolytic activity of human blood The malignant histiocytoses include Letterer-Siwe disease in monocytes. Lysis of human erythrocytes treated with anti-A children and histiocytic medullary reticulosis in adults. These serum. Clin Exp Immunol 13:29-43, 1973 23. Pels E, Den Otter W: The role of a cytophilic factor from challenged disorders are fairly well-defined clinical entities characterized immune peritoneal lymphocytes in specific macrophage cytotox­ by the proliferation of moderately differentiated mononuclear icity. Cancer Res 34:3089-3094, 1974 phagocytes in lymph nodes, bone marrow, and spleen, and often 24. Hibbs JB Jr., Lambert LH Jr., Remington JS: Control of carcino­ in skin and lung [2]. Erythrophagocytosis and thrombophago­ genesis: a possible role for the activated macrophage. Science \ cytosis are common and may lead to severe peripheral cytopen­ 177:998-1000, 1972 25. Hibbs JB Jr.: Heterocytolysis by macro phages activated by bacillus ias. Hemophagocytic reticulosis is a poorly understood but Calrnette-Guerin: Lysosome exocytosis into tumor cells. Science \ similar disorder seen in children. 184:468-471, 1974 26. Sorrell TC, Lehrer RI, Cline MJ: Mechanisms of nonspecific mac­ rophage-mediated cytotoxicity: evidence for lack of dependence SUMMARY upon oxygen. J Imrnunol, in press 27. Golde DW, Cline MJ: Regulation of granulopoiesis. N Engl J Med The mononuclear phagocyte cell line has several morpholog­ 291:1388-1395, 1974 ically defined cell types at different levels of maturation, in­ 28. Chervenick P A, LoBuglio AF: Human blood monocytes: Stimula­ cluding promonocytes, monocytes, and tissue macro phages. tors of granulocyte and mononuclear colony formation in vitro. Each of these has a characteristic composition, function, and Science 178:164, 1972 metabolism. Mononuclear phagocytes are involved in "house­ 29. Golde DW, Cline MJ: Identification of the colony-stimulating cell in human peripheral blood. J Clin Invest 51:2981-2983, 1972 keeping" functions, in microbicidal defense, and in the afferent 30. Golde DW, Territo MC, Finley TN, Cline MJ: Defective lung and efferent limbs of the immune response. They may interact macrophages in pulmonary alveolar proteinosis. Ann Intern Med with many other cells in hematopoiesis. Disorders of mononu­ 85:304-309, 1976 clear phagocyte function and differentiation have been identi­ 31. Cline MJ, Golde DW: A review and reevaluation of the histiocytic \ disorders. Am J Med 55:49-60, 1973 fied. These include (i) storage diseases based on macrophage 32. Miescher PA, Farquet JJ: Chronic myelomonocytic leukemia in enzyme deficiencies, (ii) defects in macrophage chemotaxis or adults. Semin Hematol 11:129-136, 1974